Cefpiramide
Specifications
70797-11-4CAS Number
(6R,7R)-7-[[(2R)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1H-pyridine-3-carbonyl)amino]acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidIUPAC Name
C25H24N8O7S2Chemical Formula
612.6 g/molMolecular Weight
cefpiramide; 70797-11-4; Cefpiramido; Cefpiramidum; Cefpiramida; DTXSID6046630; (6R,7R)-7-[[(2R)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1H-pyridine-3-carbonyl)amino]acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; WY-44635; WY-44,635; P936YA152N; NSC-759869; DTXCID4026630; CHEBI:59213; SM-1652; (6R,7R)-7-[(2R)-2-[(4-hydroxy-6-methylpyridin-3-yl)formamido]-2-(4-hydroxyphenyl)acetamido]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((4-hydroxy-6-methyl-3-pyridinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(R*)))-; (6R,7R)-7-(((2R)-2-(4-hydroxyphenyl)-2-((6-methyl-4-oxo-1H-pyridine-3-carbonyl)amino)acetyl)amino)-3-((1-methyltetrazol-5-yl)sulfanylmethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-((2R)-2-((4-hydroxy-6-methylpyridin-3-yl)formamido)-2-(4-hydroxyphenyl)acetamido)-3-(((1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; cefpiramide, sodium salt; RefChem:918192; J01DA27; Cefpiramide acid; MFCD00864893; (7R)-7-[[(2R)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1H-pyridine-3-carbonyl)amino]acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; NCGC00167444-01; SM 1652; (6R,7R)-7-((R)-2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; C25H24N8O7S2; WY 44,635; Cefpiramidum [INN-Latin]; Cefpiramido [INN-Spanish]; UNII-P936YA152N; Cefpiramide [USAN:USP:INN]; WY 44635; Cefpiramide (USP/INN); CEFPIRAMIDE [MI]; CEFPIRAMIDE [INN]; CEFPIRAMIDE [USAN]; CEFPIRAMIDE [MART.]; SCHEMBL49253; SCHEMBL49254; CEFPIRAMIDE [USP-RS]; CEFPIRAMIDE [WHO-DD]; orb1224177; orb1310901; CHEMBL1201204; GTPL12027; CEFPIRAMIDE [USP IMPURITY]; GLXC-23146; HMS3715H12; HY-B1354; Tox21_112448; EBC-27386; MSK157168; s5186; AKOS025311237; CCG-221235; DB00430; NSC 759869; NCGC00167444-04; (6R,7R)-7-((R)-2-(4-Hydroxy-6-methylnicotinamido)-2-(p-hydroxyphenyl)acetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; AS-14170; CAS-70797-11-4; CS-0013097; NS00011570; D03428; EN300-19766072; Q4921174; BRD-K92872987-001-01-1; BRD-K92872987-001-02-9; BRD-K92872987-236-03-9; Cefpiramide acid;Cefpiramido;Cefpiramidum;WY-44635;SM-1652; (6R,7R)-7-{[(2R)-2-(4-Hydroxy-6-methylpyridine-3-carboxamido)-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-{[(4-hydroxy-6-methylpyridin-3-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-[(2R)-2-{[(4-hydroxy-6-methylpyridin-3-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetamido]-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acidSynonyms
